We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genus Lifesciences Contests FDA’s Approval of Cocaine Hydrochloride Drug
Genus Lifesciences Contests FDA’s Approval of Cocaine Hydrochloride Drug
Genus Lifesciences has filed suit against the FDA in the U.S. District Court for the District of Columbia, alleging that the agency violated the 5-year exclusivity of a Genus product in approving a competitor’s application for a rival product.